Insider · CIK 0001966379
Akinobu Yorihiro
Files at NWTG (Sacks Parente Golf, Inc.). First filing -, latest -.
In brief
Akinobu Yorihiro files SEC Form 4 as director and officer at NWTG (Sacks Parente Golf, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Akinobu Yorihiro has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 24, 2026 | NWTG Sacks Parente Golf, Inc. | AGrant or award Common Stock | +261,780 | $0.00 | $0 | 498,870 | Jun 26, 2026 |
| Dec 18, 2025 | NWTG Sacks Parente Golf, Inc. | AGrant or award Common Stock | +225,000 | $0.00 | $0 | 237,090 | Dec 22, 2025 |
| Dec 20, 2024 | NWTG Sacks Parente Golf, Inc. | AGrant or award Options to Purchase Common Stockderivative | +25,000 | $0.00 | $0 | 25,000 | Dec 26, 2024 |
Questions about Akinobu Yorihiro
Answered from the filings on this page, as of the latest one.
Is Akinobu Yorihiro buying or selling?
Akinobu Yorihiro has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Akinobu Yorihiro's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Akinobu Yorihiro has 0.
Where does Akinobu Yorihiro file Form 4?
Akinobu Yorihiro has filed Form 4 at NWTG (Sacks Parente Golf, Inc.) as Chief Technology Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.